Tower Research Capital (TRC)’s P3 Health Partners PIII Stock Holding History
Bought
Maintained
Sold
Other funds holding PIII
Tower Research Capital (TRC)'s PIII Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its P3 Health Partners (PIII) stake by 27% in Q3 2026, selling an estimated $1.38K and leaving 396 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #5037.
Tower Research Capital (TRC) first reported a position in PIII in Q2 2021 and has held it in 16 quarters since. The position peaked at $63.6K in Q3 2023. 22 funds tracked by Wall St. Rank hold PIII as of Q3 2026.
- Tower Research Capital (TRC) held 396 shares of P3 Health Partners worth $2.68K as of Q3 2026.
- Tower Research Capital (TRC) sold 144 P3 Health Partners shares in Q3 2026, an estimated $1.38K.
- P3 Health Partners made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5037 holding.
- Tower Research Capital (TRC) first reported a position in P3 Health Partners in Q2 2021 and has held it in 16 quarters since.
- Tower Research Capital (TRC)'s P3 Health Partners position peaked at $63.6K in Q3 2023.
- 22 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.